AZD7295

DRUG4 trials

Sponsors

Arrow Therapeutics, AstraZeneca

Conditions

HealthyHealthy SubjectsHepatitis C

Phase 1

Antiviral Activity of AZD7295 in HCV Carriers

CompletedNCT00781976

Arrow TherapeuticsHepatitis C

Start: 2008-11-30End: 2010-03-31Updated: 2010-03-31

Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese

CompletedNCT00818129

AstraZenecaHealthy Subjects

Start: 2008-12-31End: 2009-05-31Target: 62Updated: 2009-07-23

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

CompletedNCT00906256

Arrow TherapeuticsHealthy

Start: 2009-04-30End: 2009-07-31Updated: 2010-02-12

Pharmacokinetics of AZD7295 Capsules

CompletedNCT01097408

Arrow TherapeuticsHealthy

Start: 2010-03-31End: 2010-08-31Updated: 2010-08-09